66 results
Page 2 of 4
8-K
EX-99.1
ohbyjpnn
27 Jun 22
Entry into a Material Definitive Agreement
7:31pm
8-K
EX-99.1
27igkwh3k2 jbz7tp8el
16 Jun 22
Other Events
7:00am
8-K
EX-99.1
vp6ng 1q6bpc
28 Feb 22
Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones
4:36pm
8-K
EX-99.1
6dwj8mh2 1tjxg
10 Jan 22
Regulation FD Disclosure
7:01am
8-K
EX-99.1
2roppae r71vr399u
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.2
kzosxe b4l4ap2h
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
1dkpmlrgvv60
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.1
lfz60nwb65w70
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
8-K
EX-99.2
oaq3cmycxuime gb
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
8-K
EX-99.1
yicqd
9 Aug 21
Business Highlights and Anticipated Second Half 2021 Milestones
7:01am
8-K
EX-99.1
7be vr4f3fav3
19 May 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.2
58tgt7ph82d
19 May 21
Regulation FD Disclosure
5:00pm